| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2012-09-06 15:16:49 UTC |
|---|
| Update Date | 2022-03-07 02:51:40 UTC |
|---|
| HMDB ID | HMDB0014578 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | Cyproheptadine |
|---|
| Description | Cyproheptadine, also known as ciprovit or antergan, belongs to the class of organic compounds known as dibenzocycloheptenes. Dibenzocycloheptenes are compounds containing a dibenzocycloheptene moiety, which consists of two benzene rings connected by a cycloheptene ring. Cyproheptadine is a drug which is used for treatment of perennial and seasonal allergic rhinitis, vasomotor rhinitis, allergic conjunctivitis due to inhalant allergens and foods, mild uncomplicated allergic skin manifestations of urticaria and angioedema, amelioration of allergic reactions to blood or plasma, cold urticaria, dermatographism, and as therapy for anaphylactic reactions adjunctive to epinephrine. Cyproheptadine is a very strong basic compound (based on its pKa). In humans, cyproheptadine is involved in cyproheptadine h1-antihistamine action. It is a sedating antihistamine with antimuscarinic and calcium-channel blocking actions. Unlike other antihistamines, it is also a seratonin receptor antagonist, making it useful in conditions such as vascular headache and anorexia. The product resulting from the formal oxidative coupling of position 5 of 5H-dibenzocycloheptene with position 4 of 1-methylpiperidine resulting in the formation of a double bond between the two fragments. Cyproheptadine is a potentially toxic compound. It is used (particularly as the hydrochloride sesquihydrate) for the relief of allergic conditions including rhinitis, conjunctivitis due to inhalant allergens and foods, urticaria and angioedema, and in pruritic skin disorders. |
|---|
| Structure | CN1CCC(CC1)=C1C2=CC=CC=C2C=CC2=CC=CC=C12 InChI=1S/C21H21N/c1-22-14-12-18(13-15-22)21-19-8-4-2-6-16(19)10-11-17-7-3-5-9-20(17)21/h2-11H,12-15H2,1H3 |
|---|
| Synonyms | | Value | Source |
|---|
| 1-Methyl-4-(5-dibenzo(a,e)cycloheptatrienylidene)piperidine | ChEBI | | 1-Methyl-4-(5H-dibenzo(a,D)cycloheptenylidene)piperidine | ChEBI | | 4-(5-Dibenzo(a,D)cyclohepten-5-ylidine)-1-methylpiperidine | ChEBI | | 4-(5H-Dibenzo(a,D)cyclohepten-5-ylidene)-1-methylpiperidine | ChEBI | | 4-Dibenzo[a,D]cyclohepten-5-ylidene-1-methyl-piperidine | ChEBI | | 5-(1-Methylpiperidylidene-4)-5H-dibenzo(a,D)cyclopheptene | ChEBI | | Ciproheptadina | ChEBI | | Cyproheptadinum | ChEBI | | Ciprovit | Kegg | | Antergan | HMDB | | Periactin | HMDB | | Peritol | HMDB | | Viternum | HMDB | | Dihexazin | HMDB |
|
|---|
| Chemical Formula | C21H21N |
|---|
| Average Molecular Weight | 287.3981 |
|---|
| Monoisotopic Molecular Weight | 287.167399677 |
|---|
| IUPAC Name | 1-methyl-4-{tricyclo[9.4.0.0³,⁸]pentadeca-1(15),3,5,7,9,11,13-heptaen-2-ylidene}piperidine |
|---|
| Traditional Name | periactin |
|---|
| CAS Registry Number | 129-03-3 |
|---|
| SMILES | CN1CCC(CC1)=C1C2=CC=CC=C2C=CC2=CC=CC=C12 |
|---|
| InChI Identifier | InChI=1S/C21H21N/c1-22-14-12-18(13-15-22)21-19-8-4-2-6-16(19)10-11-17-7-3-5-9-20(17)21/h2-11H,12-15H2,1H3 |
|---|
| InChI Key | JJCFRYNCJDLXIK-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as dibenzocycloheptenes. Dibenzocycloheptenes are compounds containing a dibenzocycloheptene moiety, which consists of two benzene rings connected by a cycloheptene ring. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Benzenoids |
|---|
| Class | Dibenzocycloheptenes |
|---|
| Sub Class | Not Available |
|---|
| Direct Parent | Dibenzocycloheptenes |
|---|
| Alternative Parents | |
|---|
| Substituents | - Dibenzocycloheptene
- Piperidine
- Tertiary aliphatic amine
- Tertiary amine
- Azacycle
- Organoheterocyclic compound
- Organic nitrogen compound
- Organopnictogen compound
- Hydrocarbon derivative
- Organonitrogen compound
- Amine
- Aromatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aromatic heteropolycyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Not Available | Not Available |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | 215 - 217 °C | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | 0.014 g/L | Not Available | | LogP | 4.7 | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 7.76 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 11.3823 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 2.36 minutes | 32390414 | | AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid | 40.8 seconds | 40023050 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 1644.3 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 260.9 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 177.9 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 181.9 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 135.1 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 436.0 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 461.2 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 419.5 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 1073.8 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 358.1 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 1137.4 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 287.2 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 343.5 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 313.8 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 309.3 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 7.8 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatized |
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - Cyproheptadine GC-MS (Non-derivatized) - 70eV, Positive | splash10-05g0-1090000000-7d19fca2a65a93c449d6 | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Cyproheptadine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | | MS | Mass Spectrum (Electron Ionization) | splash10-00kr-2290000000-a17c27a9f171b058f2c3 | 2014-09-20 | Not Available | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Experimental LC-MS/MS | LC-MS/MS Spectrum - Cyproheptadine LC-ESI-qTof , Positive-QTOF | splash10-000i-0290000000-964629904e89d79568d8 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Cyproheptadine , positive-QTOF | splash10-000i-0290000000-964629904e89d79568d8 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Cyproheptadine 35V, Positive-QTOF | splash10-000m-6790000000-4e9938638118593eb406 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Cyproheptadine 10V, Positive-QTOF | splash10-000i-1090000000-3117ec5d9639f751f7b7 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Cyproheptadine 20V, Positive-QTOF | splash10-000i-3290000000-2935111fa6fa07111de6 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Cyproheptadine 40V, Positive-QTOF | splash10-00r6-9370000000-df84a6a14decead8dedf | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Cyproheptadine 10V, Negative-QTOF | splash10-000i-0090000000-78685e74ff4bff75d39b | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Cyproheptadine 20V, Negative-QTOF | splash10-000i-0090000000-cb222eada7f0bf316df6 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Cyproheptadine 40V, Negative-QTOF | splash10-022i-5190000000-4e162fb598e8db9d6e77 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Cyproheptadine 10V, Positive-QTOF | splash10-000i-0090000000-107477c8d28ce3506c90 | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Cyproheptadine 20V, Positive-QTOF | splash10-000i-0090000000-c2a155a089dd265a5433 | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Cyproheptadine 40V, Positive-QTOF | splash10-05mo-4190000000-eaa52ca5faae687ab50f | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Cyproheptadine 10V, Negative-QTOF | splash10-000i-0090000000-26c7f893d45bf33544e2 | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Cyproheptadine 20V, Negative-QTOF | splash10-000i-0090000000-2c051f1f630ec47ecb1c | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Cyproheptadine 40V, Negative-QTOF | splash10-00lr-0090000000-012e0121acf874e7bd11 | 2021-09-24 | Wishart Lab | View Spectrum |
|
|---|